Check SCREEN READER MODE to make this survey compatible with screen readers.
EPA Survey on Digitalisation in European Psychiatry
Samochowiec J, Volpe U, Gaebel W, Falkai P, Dom G, Schouler Ocak M, De Picker L, Krzystanek M, Rojnic Kuzman M et al
Dear Colleagues,
Digital technology might offer psychiatry the potential for radical change in terms of service delivery and the development of new treatments. However, it also carries the risk of commercialised, unproven treatments entering the medical marketplace with detrimental effect. Novel research methods, transparency standards, clinical evidence, and care delivery models must be created in collaboration with a wide range of stakeholders. Psychiatrists need to remain up to date and educated in the evolving digital world.
In order to facilitate discussion and collaboration, a Task Force group working under the umbrella of the National Psychiatric Associations Council prepared a questionnaire gathering information on Digitalisation in European Psychiatry (“DEP Survey”)
The aims of EPA Survey on Digitalisation in European Psychiatry (“DEP Survey”) are:
1. To gather information on the e-mental health tools available in a given country, the availability of remote synchronous telemedical appointments and its status as standard of care.
2. To collect the respondent's recommendations regarding the use and usefulness of remote synchronous telemedical appointments in various forms, places and situations in a given country and the proportion in which remote medical service can be provided compared to face-to-face visits.
3. To gather information on financing, recommendations on duration of remote synchronous telemedical appointments, forms of remote contact, its advantages and disadvantages and legal framework regarding telemedicine in a given country.
4. To gather opinions in the form of open comments on the limitations on the use of telemedical services in a given country and changes in telemedicine caused by the CIVID-19 pandemic.
Please share with us practices on this issue in your country by filling the questionnaire below on behalf of your National Psychiatric Association.